Our leaders combine over 85 years of experience in the healthcare and pharmaceutical industry.
Together our team launched the first vaginal pH modulator, a unique mechanism of action, to bring much-needed non-hormonal innovation to the contraceptive space with Phexxi® (lactic acid, citric acid and potassium bitartrate) vaginal gel.
Chief Executive Officer
Saundra Pelletier has served as Chief Executive Officer, President and Executive Director of Evofem Biosciences since February 2015, and as interim Chair of the Board since November 2021. She has been responsible for the company’s growth and evolution, led Evofem’s transition to the public market in January 2018, and led multiple equity financing rounds which have raised over $500 million.
Chief Financial Officer and Secretary
Ivy Zhang is a trusted leader and seasoned finance executive with more than 14 years of financial and accounting experience spanning diverse industries, including pharmaceuticals and medical devices, who is dedicated to advancing Evofem Biosciences’ mission of addressing the unmet sexual and reproductive health needs of women. She joined Evofem as Chief Financial Officer and Secretary in April 2023 and leads the Company’s finance organization and financial activities including financial planning and analysis, accounting, external audit, tax, controllership, and treasury functions.
Chief of Staff
Ellen Thomas, Evofem Biosciences’ Chief of Staff, has over 30 years of professional experience in board management and corporate governance, healthcare communications, global operations, marketing, thought leader engagement, global meeting/conference event management, pharmaceutical sales, continuing medical education and management consulting. She joined Evofem in January 2013 and has worked for Saundra Pelletier since July 2009.
Senior Vice President, Investor Relations
Amy Raskopf has more than 24 years of experience planning and executing investor relations (IR) programs for public and private companies, predominantly working with companies in the healthcare sector whose products have the potential to significantly improve patients’ lives. Ms. Raskopf joined Evofem in February 2018 and, since December 2022, also serves as interim head of business development.
Rachael Hildebrandt, PHR, SHRM-CP
Head of Human Resources
Rachael Hildebrandt is the Head of Human Resources for Evofem Biosciences. She brings over 22 years of broad human resources leadership and operations expertise. Since joining Evofem Biosciences in 2015, she has served on our executive management team leading all our human resources functions. Her experience includes talent acquisition, policy design and development, compliance, performance management, employee experience, and total rewards strategies.